Vitiligo trials in Taiwan

2 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients

  Where

  Kaohsiung City, Taoyuan

  Age

  18 years to 65 years

  People

  45 worldwide

  Run by

  Elixiron Immunotherapeutics (Hong Kong) Ltd.

  See details and how to joinNCT07223229
• No phaseTaking people
  A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa

  Where

  Taipei, Taoyuan City

  Age

  12 years and over

  People

  2,795 worldwide

  Run by

  AbbVie

  See details and how to joinNCT07136467